Today Got Better
Subscribe free

Life Sciences & Medicine Active Updated Oct 14, 2026

Muscarinic drugs for schizophrenia

Where it stands as of Oct 14, 2026

Psychiatric Times is running pieces on muscarinic treatment in psychosis and on emerging schizophrenia mechanisms beyond dopamine, a sign the field is treating the dopamine hypothesis as incomplete. The reporting is commentary and review rather than new trial results. How well muscarinic drugs perform against existing treatments over the long term is not yet established.

The story so far

  1. Oct 14, 2026 Latest

    Psychiatric Times published a piece rethinking the dopamine hypothesis around upstream circuits and muscarinic treatment in psychosis, alongside a review of the schizophrenia pipeline and mechanisms beyond dopamine.

    Today Got Better

This story moves with the morning letter.

When this question gets a new answer, the page above changes the same morning. Each morning's letter brings the day's progress in science, medicine and beyond. Free, every day.